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Background: Identification of acute HIV infection (AHI) allows for im-
portant opportunities for HIV prevention through behavior change and bio-
medical intervention. Here, we evaluate changes in sexual risk behaviors
among persons with AHI enrolled in a combined behavioral and biomedi-
cal intervention designed to reduce onward transmission of HIV.
Methods: Participants were randomized to standard HIV counseling, a
multisession behavioral intervention, or a multisession behavioral inter-
vention plus antiretrovirals. Sexual behaviors were assessed periodically
over 1 year.
Results: Four weeks after diagnosis, the predicted probability of reporting
multiple sexual partners decreased from 24% to 9%, and the probability of
reporting unprotected sex decreased from 71% to 27%. These declines in sex-
ual risk behaviors were sustained over follow-up irrespective of study arm.
Conclusions: Diagnosis of AHI alone may be sufficient to achieve im-
mediate and sustained behavior change during this highly infectious period.
Identification of acute HIV infection (AHI) allows for importantopportunities for HIV prevention. AcuteHIV infection, compris-
ing the first few weeks of HIV infection before antibody develop-
ment,1 is characterized by increased infectiousness due to high
viral burden and per-virion infectivity.2–4 Immediate linkage to
care and initiation of antiretrovirals (ARVs) during AHI may im-
prove immune function,5–8 limit the size of the HIV reservoir,9–11
and reduce transmission risk through viral suppression.7,12,13 Di-
agnosis during AHI can also lead to important transmission pre-
vention benefits through infection awareness and subsequent
behavior change.14–16 Although AHI accounts for a relative mi-
nority (2%–10%) of new diagnoses in settings where AHI test-
ing has been performed,17 interventions during this period of
heightened infectiousness can have a disproportionate impact
on population-level HIV spread.18
Interventions aimed at rapidly decreasing risky sexual be-
haviors during the brief acute window are especially critical
among persons with AHI because even immediate ARV initiation
does not instantaneously reduce viral load.19–21 In Malawi, where
an estimated 10% of the adult population is HIV infected and 38%
of all new heterosexually acquired infections may be due to con-
tact with persons with AHI,18 diagnosis during the acute window
in combination with risk reduction education or counseling is as-
sociated with a rapid reduction in self-reported transmission risk
behaviors.22,23 However, the extent to which behavior change is
sustained beyond the immediate post-diagnosis phase is unknown.
In this investigation, we evaluate both the immediate and
sustained changes in sexual risk behaviors among persons with
AHI enrolled in a combined behavioral and biomedical inter-
vention designed to reduce onward transmission of HIV over
a 1-year period.
METHODS
Study Design and Index Recruitment
This investigation was part of a trial that evaluated the fea-
sibility and acceptability of a behavioral intervention (BI) and
short-term ARV use among persons diagnosed as having AHI in
Lilongwe, Malawi (ClinicalTrials.gov No. NCT01450189).24 Re-
cruitment was from 2 HIV testing and counseling centers and 2
sexually transmitted infections clinics. Primary study participants
(index participants) were persons 18 years or older with AHI en-
rolled between June 2012 and January 2014.
Routine HIV testing using standard serial rapid testing was
offered with Alere Determine HIV-1/2 (Alere, Inc, Waltham, MA)
and Uni-Gold Recombigen HIV-1/2 (Trinity Biotech, Bray, Ireland)
rapid antibody tests, as perMalawi national guidelines. Personswho
tested positive for established (antibody-positive) HIV infection
were referred to a nearby facility for routine HIV care. Persons
who tested HIV-antibody (Ab) negative or Ab discordant were of-
fered screening for AHI using a pooled HIV RNA polymerase
chain reaction algorithm.25 Acute HIV infection was defined as
Ab-negative or Ab-discordant rapid tests with detectable HIV
RNA. Persons found to have AHI were traced and asked to return
to the clinic, where they were counseled on their results and pro-
vided additional information on AHI. At the time of AHI screen-
ing, a short questionnaire was administered to assess eligibility.
Full eligibility criteria and detailed screening procedures have
been published elsewhere.24 Irrespective of eligibility status or
the decision to enroll in the study, all persons with AHI were re-
ferred for routine HIV care.
Eligible patients with AHI were offered enrollment and ran-
domized in a 1:2:2 ratio (blocked randomization with block sizes
of five, stratified by sex) to 1 of 3 groups: (1) standard counseling
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(SC), (2) a multisession BI, and (3) the same multisession BI plus
a short-course of ARVs (BIA). Participants randomized to the SC
group received a standard posttest counseling session that encour-
aged behaviors to reduce transmission risk and were provided in-
formation on AHI.
In addition to SC, participants randomized to the BI and
BIA arms received 4 motivational interviewing counseling ses-
sions and 1 “booster” session over an 8-week period. The
patient-centered sessions were based on the IMB Model, which
has been shown to reduce sexual risk behaviors among people
living with HIV.22,26 Each session was designed to provide par-
ticipants with the tools needed to abstain or practice protected
sex during the brief AHI period, while also planning for long-
term behavioral risk reduction. Participants randomized to the
BIA group were also provided a 12-week course of ARVs
(raltegravir [400 mg orally twice a day] and emtricitabine/
tenofovir [FTC/TDF; 200/300 mg orally once a day]) and com-
pleted supplementary counseling on potential adverse effects
and the importance of ARV adherence.
This trial was approved by the Biomedical Institutional Re-
view Board of the University of North Carolina at Chapel Hill and
the National Health Sciences Research Committee of Malawi.
Written informed consent was obtained from all participants.
Data Collection and Follow-Up
Study enrollment occurred after participants were traced
and notified of their acute status, approximately 1 week after
screening. Baseline questionnaires were completed at study enroll-
ment in English or Chichewa using audio computer-assisted self-
interview software. Participants in all study arms also completed
questionnaires at weeks 1, 2, 4, 8, 12, 19, 26, 39, and 52. Question-
naires collected information on demographics (baseline), sexual
risk behaviors in the last month (baseline and week 4 onward),
and knowledge of acute and established HIV infection (baseline).
Detailed information on demographics and sexual risk behaviors
for up to 5 sexual partners was also collected at each study visit.
Outcomes
The primary aim of this analysis was to describe changes in
sexual risk behaviors after AHI diagnosis across all index partic-
ipants, with a secondary focus on assessing changes by interven-
tion arm. Specifically, we assessed 2 dichotomous variables at
each visit: (1) vaginal sex with multiple (>1) partners in the pre-
ceding month (yes/no) and (2) any unprotected vaginal sex in the
preceding month (yes/no). We also descriptively assessed the
proportion of participants reporting sex with steady versus casual
partners in the preceding month at each time point.
Statistical Analyses
In baseline analyses, characteristics for enrolled partici-
pants were evaluated overall and by study arm. In longitudinal
analyses, we used generalized estimating equations with a logistic
link to assess whether there had been an overall decline after base-
line in the proportions of participants reporting (1) multiple sexual
partners and (2) any unprotected sex. We fit a model for each out-
come, specifying time since diagnosis as the only explanatory
variable. Robust variance estimators with an exchangeable correla-
tion matrix were used to account for within-subject correlation.27
We calculated predicted probabilities and 95% confidence intervals
(CIs) for each outcome at weeks 4, 8, 12, 19, 26, 39, and 52. In sec-
ondary analyses, we included intervention status as an additional ex-
planatory variable in both models. Because of sparse data, we
combined persons in the BI and BIA arms to compare outcomes be-
tween persons who did and did not receive the BI (i.e., BI or BIA
intervention vs. SC). No adjustment variables were included given
the study's randomized design, and intent-to-treat analyses were
used to assess both outcomes.
Additional analyses were also conducted to assess trends
over time in the proportions reporting steady versus casual part-
ners, overall and by intervention status. All statistical analyses
were performed using SAS statistical software (version 9.4;
Cary, NC).
RESULTS
Baseline Characteristics
Among 9171 persons testing Ab negative or Ab discordant
for HIV infection between June 2012 and January 2014, 59 (0.6%)
were diagnosed as having AHI.24 Of the 59 persons with AHI, 46
(78%) were enrolled in the study and randomized to 1 of the 3
study arms (9 SC, 18 BI, 19 BIA). Themedian time between initial
AHI screening and study enrollment was 7 days (interquartile
range [IQR], 6–11 days; Table 1).
The average participant was 25 years of age (IQR,
22–32 years). Consistent with the proportion of men and women
identified with AHI, most participants were male (28/46; 61%).
More than two thirds were married or living with a steady partner.
Nearly all participants in the SC arm (8/9; 89%) were married or
living with a steady partner compared with 12 (67%) of 18 in
the BI arm and 13 (68%) of 19 in the BIA arm.
Behavioral Intervention
Most (30/37; 81%) participants in the BI and BIA arms
completed all 4 behavioral sessions, and median time to session
completion (excluding the booster session) was 16 days (IQR,
14–18 days). Loss to follow-up was observed across all arms. At
week 26, 80% of participants were still retained in the study
(SC, 89%; BI, 78%; BIA, 79%). By week 52, 59% were retained
(SC, 67%; BI, 56%; BIA, 58%).
Multiple Sexual Partners
At baseline, approximately a quarter of all participants (12/
45; 27%) reported multiple partners in the previous month (Table 1).
The proportion of participants reporting multiple partners in the
last month was highest in the BI arm (6/17; 35%) and lowest in
the SC arm (1/9; 11%). Compared with those not reporting multi-
ple partners in the last month, a greater proportion of participants
reporting multiple partners in the last month were male (9/12
[75%] vs. 19/33 [58%]) and married or living with a partner (10/12
[83%] vs. 22/33 [67%]).
On the basis of our observation of an immediate, substan-
tial decrease in the proportion of participants reporting multiple
partners in the last month, followed by a comparatively slower de-
cline thereafter, we included a linear spline term beginning at week
4 to model changes over the study period (Fig. 1A). At baseline,
the predicted probability of reporting multiple partners was 24%
(95% CI, 15%–38%). At week 4, the predicted probability
decreased to 9% (95% CI, 5%–17%). By the end of follow-up,
the predicted probability of reporting multiple partners was 3%
(95% CI, 1%–8%). In secondary analysis, a dichotomized term
for intervention status (intervention vs. SC) was not associated
with reporting of multiple partnerships in the last month; however,
precision was low.
Unprotected Sex
At baseline, nearly all participants (32/45; 71%) reported
one or more acts of unprotected vaginal sex in the past month
(Table 1), with similar proportions across intervention arms. Com-
pared with participants who did not report unprotected sex, a
greater proportion of participants reporting unprotected sex were
male (21/32 [66%] vs. 7/13 [54%]) and married or living with a
spouse or partner (26/32 [71%] vs. 7/13 [54%]).
As with our assessment of multiple partners, we observed
an immediate decrease in the proportion of participants reporting
unprotected sex in the last month, followed by a much slower de-
cline. We similarly included a linear spline term beginning at week
4 to model changes in unprotected sex over the study period
(Fig. 1B). We observed a sharp decrease in unprotected sex at
week 4 (predicted probability, 27% [95% CI, 19%–39%])
relative to baseline (predicted probability, 71% [95% CI, 57%–
83%]). After week 4, the predicted probability of unprotected
sex remained relatively constant; at the end of follow-up, the
predicted probability of unprotected sex in the previous month
was 20% (95% CI, 10%–36%). In secondary analysis, a
dichotomized term for intervention status (intervention vs. SC)
was not associated with reporting of unprotected sex in the last
month. Precision was low.
Sex with Steady and Casual Partners
At baseline, more than half of participants (23/45; 51%) re-
ported sex with one or more steady partners (e.g., spouse or live-in
boyfriend/girlfriend) in the previous month, and 20 (44%) of 45
reported sex with one or more casual partners (e.g., non–live-in
boyfriend/girlfriend or other partner outside an established rela-
tionship; Table 2). Results were similarly by intervention arm.
Although the proportion of participants reporting sexwith a
steady partner remained relatively constant over follow-up, we ob-
served a consistent decrease in the proportion of participants reporting
sex with a casual partner. By week 4, the proportion reporting sex
with a casual partner decreased to 22% (from 44% at baseline). By
the end of follow-up, this proportion had decreased to just 4%.When
assessed by intervention status, this trend persisted in both the
combined intervention arm and the SC arm.
DISCUSSION
We conducted a longitudinal study of 46 persons who had
been diagnosed as having AHI in Lilongwe, Malawi. This study's
prospective design, which included frequent and detailed assess-
ments of sexual risk behaviors over 1 year, was uniquely suited
to measure behavior change after diagnosis. We found a decrease
in sexual risk behaviors after AHI diagnosis that was sustained for
the remainder of the 1-year follow-up period.
Immediately decreasing sexual risk behavior in persons
with AHI is critical given the high probability of transmission dur-
ing this period. Even among persons who are linked to care and
treated during the acute window, transmission efficiency via unpro-
tected sex remains high until viral suppression is achieved.17,19,20 In
TABLE 1. Baseline Demographics and Sexual Risk Behaviors Among Patients with AHI (N = 46)
Characteristic
Overall (N = 46),
Median (IQR)
SC (n = 9),
Median (IQR)
BI (n = 18),
Median (IQR)
BIA (n = 19),
Median (IQR)
Age, years 25.0 (22–32) 32.0 (26–38) 24.5 (23–29) 25.0 (22–30)
Time between screening and receipt of results, days 7.0 (6–11) 7.0 (5–7) 7.0 (6–11) 9.0 (7–12)
No. sexual acts, last month 5.5 (1–12) 4.0 (1–7) 6.0 (2–15) 6.0 (1–14)
n (%) n (%) n (%) n (%)
Sex
Male 28 (60.9) 5 (55.6) 11 (61.1) 12 (63.2)
Female 18 (39.1) 4 (44.4) 7 (38.9) 7 (36.8)
Married or living with a steady partner
Yes 33 (71.7) 8 (88.9) 12 (66.7) 13 (68.4)
No 13 (28.3) 1 (11.1) 6 (33.3) 6 (31.6)
Education
≤Primary completed 26 (56.5) 6 (66.7) 8 (44.4) 12 (63.1)
Some secondary 12 (26.1) 1 (11.1) 5 (27.8) 6 (31.6)
≥Secondary completed 8 (17.4) 2 (22.2) 5 (27.8) 1 (5.3)
Employment status
Employed 30 (65.2) 7 (77.8) 11 (61.1) 12 (63.2)
Not employed 16 (34.8) 2 (22.2) 7 (38.9) 7 (36.8)
Total partners, last 3 months*
≤1 25 (55.6) 5 (55.6) 7 (41.2) 13 (68.4)
>1 20 (44.4) 4 (44.4) 10 (58.8) 6 (31.6)
Total partners, last month*
≤1 33 (73.3) 8 (88.9) 11 (64.7) 14 (73.7)
>1 12 (26.7) 1 (11.1) 6 (35.3) 5 (26.3)
Total partners since screening
≤1 41 (89.1) 9 (100) 15 (83.3) 17 (89.5)
>1 5 (10.9) 0 (0) 3 (16.7) 2 (10.5)
Unprotected sex, last month*
No 13 (28.9) 2 (22.2) 5 (29.4) 6 (31.6)
Yes 32 (71.1) 7 (77.8) 12 (70.6) 13 (68.4)
Unprotected sex since screening*
No 33 (73.3) 5 (55.6) 16 (48.5) 12 (63.2)
Yes 12 (26.7) 4 (44.4) 1 (5.9) 7 (36.8)
AHI indicates acute HIV infection; SC, standard counseling; BI, behavioral intervention; BIA, behavioral intervention plus treatment; IQR, interquartile
range.
*n = 45; 1 index patient randomized to the BI arm missing sexual behaviors.
our study, participants reduced their probability of having multiple
partners and decreased their overall probability of unprotected sex
within 4 weeks of learning their acute status.
Among persons with multiple partners, concurrent partner-
ships and consecutive partnerships separated by short temporal
gaps are thought to facilitate the spread of HIVand STIs.28 A for-
mal assessment of concurrency was beyond the scope of this anal-
ysis. However, most participants in our study were either married
or living with a partner, and almost half reported sex with multiple
partners in the months preceding AHI diagnosis. The probability
of reporting multiple partners in the past month dropped from
24% at baseline to just 3% at 52 weeks, and the proportion of par-
ticipants reporting sex with casual partners sharply declined. How-
ever, we observed a high proportion of loss to follow-up at
52 weeks, and it may be possible that participants who were lost
to follow-up were more likely to report sex with multiple partners
or casual partners than those that were retained.
Participants in our study may have chosen to limit sexual
encounters with casual partners after learning their HIV status,
which may have contributed to the overall decline multiple part-
nerships. A decline in casual sexual partners and overall partner
number among persons with AHI has previously been reported
Figure 1. A, Unadjusted predicted probability of multiple sexual partners (95% CIs). B, Unadjusted predicted probability of any unprotected
sex (95%CIs). Predicted probabilities were calculated using generalized estimating equationmodeling. Panel A depicts predicted probability
of reporting multiple (>1) sex partners over the 52-week study period. There was a decrease in the predicted probability of reporting multiple
sex partners by week 4 (ranging from 24% at baseline to 9% at week 4), which was sustained over time. Panel B depicts the predicted
probability of having unprotected over the 52-week study period. By week 4, the predicted probability of unprotected sex steeply declined
(from 71% at baseline to 27% at week 4). This decrease was sustained over time. Precision was limited.
inMalawi; however, the observation period for these prior changes
did not extend past 6 months.22 We have demonstrated that,
coupled with standard risk reduction counseling, AHI diagnosis
may be sufficient to initiate a reduction in sexual partners that is
sustained over a 1-year period.
A sustained reduction in sexual partners is critical for HIV
prevention, particularly among HIV-infected persons who engage
in unprotected sex. In our study, despite a sharp decrease in unpro-
tected sex that was sustained throughout follow-up, an estimated
20% of participants were still engaging in unprotected sex at the
end of 1 year. Unfortunately, we did not have information to assess
the HIV status of the partners with whom unprotected sex was oc-
curring, so it is difficult to assess the transmission risk associated
with these unprotected acts. However, the high HIV prevalence
among referred partners (79%; unpublished data) suggests that
participants who continually engaged in unprotected sex may well
have done so with partners who were HIV positive.
Among persons with AHI, engaging in sexual activity with
a long-term or committed partner (vs. a casual partner) is thought
to reduce one's ability to negotiate condom use.23 To maximize
treatment as prevention, risk reduction strategies that advocate
abstinence or consistent condom use with all partners should be
strongly emphasized during the acute window, even in the pres-
ence of ARVs. For persons who continue to engage in unpro-
tected sex, both during the acute window and after, immediate
initiation of ARVs (potentially coupled with preexposure pro-
phylaxis for HIV-negative partners) should be made a top priority
for prevention.
Questionnaires were administered using audio computer-
assisted self-interview software to increase efficiency during data
collection and to minimize social desirability bias. To minimize
out-of-range responses and missing data resulting from user error,
robustness flags and checks were used during data collection and
data cleaning to improve internal consistency. Still, some partici-
pants may have misreported their sexual behaviors.
Our study's design and the nature of our assessment tool
precluded us from assessing specifically when participants initi-
ated a relative decrease in their sexual risk behaviors in the
4 weeks after screening. Some participants may have decreased
their sexual risk behaviors immediately after consenting to AHI
screening, either to prevent potential transmission to their partners
or for health-related reasons.
A secondary objective of this analysis was to determine if
changes in sexual risk behaviorswere associated with motivational
interviewing (plus or minus treatment with ARVs) relative to stan-
dard risk reduction counseling.We noted few differences in sexual
risk behaviors by intervention status, suggesting that diagnosis and
SC can have powerful effects. However, the precision of our
intervention-specific estimates was limited by the small size
of—and substantial loss to follow-up in—the pilot study, and
our findings should be interpreted with some caution. Further-
more, because all participants in this study received standard risk
reduction counseling, we were unable to assess whether AHI diag-
nosis alone would have similarly decreased sexual risk behaviors.
Differences in demographics by study arm were also evi-
dent despite randomization, likely resulting from the small size
of the pilot study population. To detect meaningful differences be-
tween intervention arms, a larger study would be necessary. De-
spite these limitations, our findings clearly suggest that early
diagnosis, coupled with standard risk reduction counseling, may
be sufficient to decrease sexual risk behaviors during and after
the acute period.
Although identification of AHI remains challenging,1,29
the transmission implications of AHI detection are substantial,
and both newer technologies and targeted screening approaches
can increase efficiency.24,29,30 Our previous findings24 suggest
that AHI screening is both acceptable and feasible when incorpo-
rated into routine testing procedures. As Malawi and other coun-
tries with high HIV prevalence scale up initiation of ARVs
irrespective of CD4 count, treatment as prevention will be most ef-
fective if persons with AHI are routinely identified and provided
risk reduction strategies.18 Early diagnosis and intervention during
AHI can provide several years' worth of transmission prevention
benefits beyondwhat can be achieved with diagnosis during estab-
lished infection, suggesting that expanded efforts to implement
AHI screening in at-risk populations should be a high priority.
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